Streetbeat News

Analyst Ratings

BTCUSD

ETHUSD

OCEANUSD

SOLUSD

Messari's Crypto Theses report is bullish on Bitcoin, citing its potential to reach over $600,000 by achieving parity with gold. The report also praises Solana for its transaction speeds and developer community but notes scalability challenges. Ethereum is seen as a higher risk 'beta' asset with potential for greater rewards, despite a predicted price dip in 2024. Messari highlights investments in AI-focused tokens like Ocean Protocol, Akash Network, Tao Network, and Render Network, pointing to the convergence of blockchain and AI as a key trend. The firm's transparency in disclosing analyst positions is seen as a move to enhance informed decision-making in crypto research.

Portfolio Pulse from Murtuza Merchant

December 21, 2023 | 2:18 pm

NFLX

Wedbush analyst Michael Pachter has reiterated an Outperform rating on Netflix (NASDAQ:NFLX) and maintained a price target of $525.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:15 pm

MU

Wedbush analyst Matt Bryson has reiterated an Outperform rating on Micron Technology (NASDAQ:MU) and maintained a price target of $95.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:08 pm

LQDA

Wedbush analyst Andreas Argyrides has reiterated an Underperform rating on Liquidia (NASDAQ:LQDA) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:06 pm

WEN

Wendy's (NASDAQ:WEN) received mixed analyst ratings over the past three months, with no bullish, three somewhat bullish, and three indifferent ratings. The average 12-month price target is $22.17, a 13.06% decline from the previous average. Analysts from Stephens & Co., Barclays, Citigroup, Deutsche Bank, Wedbush, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Wendy's is a major burger QSR in the U.S., with significant systemwide sales and a large number of units worldwide. The company's financials show strong net margin and ROE but a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

FROG

Analysts have provided mixed reviews on JFrog (NASDAQ:FROG) over the past three months, with a total of 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target is $32.5, with a high of $42.00 and a low of $28.00, reflecting a slight decrease of 0.52%. JFrog's financials show a revenue growth of 23.12% but below-average net margin and ROE. The company's market cap is below industry averages, and it has a low debt-to-equity ratio of 0.04. Analysts' ratings are based on future earnings predictions and company performance.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

CAKE

Cheesecake Factory (NASDAQ:CAKE) has been rated by 11 analysts in the past three months, with a shift towards a more bearish sentiment. The average 12-month price target is now $31.45, down 7.5% from previous estimates. Analysts from firms like Wedbush, Piper Sandler, Barclays, Stephens & Co., Deutsche Bank, Citigroup, Morgan Stanley, and B of A Securities have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Cheesecake Factory's financial indicators show a mixed performance with strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

MMSI

Merit Medical Systems (NASDAQ:MMSI) has received varied analyst ratings over the past three months, with 3 bullish and 1 somewhat bullish out of 4 total ratings. The average 12-month price target is $93.25, with a high of $100.00 and a low of $81.00, reflecting a 4.78% increase from the previous target of $89.00. Analysts from Canaccord Genuity, Barrington Research, and Needham have updated their ratings and price targets, indicating a positive outlook on the company's performance. Merit Medical Systems specializes in medical equipment for interventional procedures and has shown strong financial indicators such as revenue growth, net margin, ROE, ROA, and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

NVRO

Nevro (NYSE:NVRO) has received mixed analyst ratings over the last three months, with 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target is now $19.00, down from $22.12. Analysts from Canaccord Genuity, RBC Capital, Truist Securities, JP Morgan, Piper Sandler, and Morgan Stanley have adjusted their ratings and price targets. Nevro's financials show a revenue growth of 3.38%, a net margin of -22.61%, an ROE of -8.09%, an ROA of -4.15%, and a debt-to-equity ratio of 0.68.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

CMG

Wedbush analyst Nick Setyan has downgraded Chipotle Mexican Grill (NYSE:CMG) from Outperform to Neutral, while setting a price target of $2400 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 1:55 pm